Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Liabilities: 2022-2024

Historic Total Liabilities for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $43.2 million.

  • Orchestra BioMed Holdings' Total Liabilities rose 109.86% to $61.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.1 million, marking a year-over-year increase of 109.86%. This contributed to the annual value of $43.2 million for FY2024, which is 59.06% up from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Total Liabilities is $43.2 million, which was up 59.06% from $27.2 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Total Liabilities ranged from a high of $43.2 million in FY2024 and a low of $27.2 million during FY2023.
  • For the 3-year period, Orchestra BioMed Holdings' Total Liabilities averaged around $37.8 million, with its median value being $43.0 million (2022).
  • Per our database at Business Quant, Orchestra BioMed Holdings' Total Liabilities slumped by 36.87% in 2023 and then surged by 59.06% in 2024.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Total Liabilities stood at $43.0 million in 2022, then plummeted by 36.87% to $27.2 million in 2023, then surged by 59.06% to $43.2 million in 2024.